FSM Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
FSM Wealth Advisors's PFE Position: Q2 2026 in Review
FSM Wealth Advisors reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $88.3K and leaving 24,073 shares worth $580K. The position accounts for 0.06% of the portfolio, ranked #168.
FSM Wealth Advisors first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $887K in Q4 2022. 1,657 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- FSM Wealth Advisors held 24,073 shares of Pfizer worth $580K as of Q2 2026.
- FSM Wealth Advisors sold 3,377 Pfizer shares in Q2 2026, an estimated $88.3K.
- Pfizer made up 0.06% of FSM Wealth Advisors's portfolio in Q2 2026, its #168 holding.
- FSM Wealth Advisors first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
- FSM Wealth Advisors's Pfizer position peaked at $887K in Q4 2022.
- 1,657 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.